Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2014 Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
Neomycin is an aminoglycoside antibiotic.
Neomycin acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.
The absorption of neomycin from the alimentary tract is poor: Only 3% of an oral dose is absorbed, neomycin is rapidly excreted by the kidneys in the unchanged form. The plasma half-life in healthy adults is approximately 2-3 hours. Oral doses of 3g produce peak plasma concentrations of up to 4 μg/ml.
Not applicable.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
